YELENA MAGAY: Open Payments
NPI 1790198208 · ABBEVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,986 in 14 payments from 7 companies in 2025. Trend: 2023 $4,237 · 2024 $127 · 2025 $2,986
Consulting: $2,423Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 7 | $2,423 |
| Travere Therapeutics, Inc. | 2 | $173 |
| GENZYME CORPORATION | 1 | $129 |
| Calliditas Therapeutics US Inc. | 1 | $116 |
| Amgen Inc. | 1 | $95 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Mallinckrodt Hospital Products Inc. | 1 | $23 |
Products named: Filspari, FABRAZYME, TARPEYO, KRYSTEXXA, Vanrafia, ACTHAR.
Industry payments across LA — which companies pay providers there.
